Francesco S. Di Leva

Via D. Montesano 49
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Journal: Journal of medicinal chemistry

Published: February 23, 2026

Stereocontrolled Synthesis of α-Branched Tetrahydropyrans by a One-Pot-Two-Step Photobiocatalytic Cascade of Citronellol.

Stereocontrolled Synthesis of α-Branched Tetrahydropyrans by a One-Pot-Two-Step Photobiocatalytic Cascade of Citronellol.

Journal: Journal of natural products

Published: February 04, 2026

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Journal: Cancer communications (London, England)

Published: December 16, 2025

Vincristine Beyond Mitosis: Uncovering a First Link to G-Quadruplex DNA in Cancer Cells.

Vincristine Beyond Mitosis: Uncovering a First Link to G-Quadruplex DNA in Cancer Cells.

Journal: International journal of molecular sciences

Published: July 25, 2025

Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy.

Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy.

Journal: Journal of chemical information and modeling

Published: May 23, 2025

Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.

Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.

Journal: Journal of medicinal chemistry

Published: February 05, 2025

Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats.

Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats.

Journal: European journal of medicinal chemistry

Published: January 30, 2025

Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting Agents.

Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting Agents.

Journal: Journal of medicinal chemistry

Published: January 01, 2025

Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations.

Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations.

Journal: The Journal of chemical physics

Published: December 12, 2024

Pharmacological targeting of smoothened receptor cysteine-rich domain by Budesonide promotes in vitro myelination.

Pharmacological targeting of smoothened receptor cysteine-rich domain by Budesonide promotes in vitro myelination.

Journal: Frontiers in molecular neuroscience

Published: July 31, 2024

Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.

Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.

Journal: Cell death discovery

Published: May 21, 2024

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists.

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists.

Journal: Journal of medicinal chemistry

Published: February 01, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026